Work

[Stage Ⅳ HER2-Positive Breast Cancer That Showed Complete Response for Over One Year after Discontinuation of Anti-HER2 Therapy-A Case Report].

Year: 2021

Type: article

Study design: Case Report

Source: PubMed

DOI: 10.18907/jjsre.34.1_95_2

Authors: Hirofumi Terakawa, Takuya Ogaito, Koji Okamoto, Sosuke Shima, Kento Terasaki, Hiroyuki Tanaka, Masashi Hashimoto, Ryosuke Zaimoku, Ryohei Takei, Itsuro Terada, Yuji Tsukioka, Masato Kiriyama

Institution: Kurobe City Hospital

Language: Japanese

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W35046255

FWCI:

Cites:

Cited by:

Related to: 10